Summary Stage 2018: Cervix
Summary Stage 2018
Notes
**Cervix** 8000-8700, 8720-8790, 8805, 8933, 8980, 9110, 9581, 9700-9701 C530-C531, C538-C539 C530 Endocervix C531 Exocervix C538 Overlapping lesion of cervix C539 Cervix uteri **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 52 *Cervix Uteri*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following chapters for the listed histologies * 8710-8714, 8800-8804, 8806-8932, 8934, 8940-8975, 8981-9105, 9120-9137, 9141-9580, 9582: *Soft Tissue* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* **Note 3:** Para-aortic nodes are now regional instead of distant.NAACCR Item
NAACCR #764| SS2018 | Description |
|---|---|
| 0 | In situ, intraepithelial, noninvasive - Cancer in situ WITH endocervical gland involvement - Cervical intraepithelial neoplasia (CIN) Grade III - Preinvasive |
| 1 | Localized only (localized, NOS) - FIGO Stage IA1 + Measured stromal invasion 3.0 mm or less and 7.0 mm or less in horizontal spread - FIGO Stage IA2 + Measured stromal invasion 3.1 mm to 5.0 mm with a horizontal spread of 7.0 mm or less - FIGO Stage IA [NOS] + Measured stromal invasion 5.0 mm or less measured from the base of the epithelium AND horizontal spread of 7.0 mm or less - FIGO Stage IB - FIGO Stage I [NOS] + Clinically visible lesion (macroscopic), including superficial invasion + Confined to cervix uteri or uterus, NOS, except corpus uteri, NOS * (Not clinically visible or unknown if clinically visible) |
| 2 | Regional by direct extension only - FIGO Stage IIA, IIB, II [NOS] + Confined to corpus uteri, size, depth and horizontal spread unknown + Corpus uteri, NOS + Cul de sac (rectouterine pouch) + Invasion beyond uterus, NOS + Ligament(s) (broad, cardinal, uterosacral) + Parametrial (paracervical soft tissue) invasion + Upper two-thirds of vagina including fornices + Vagina, NOS + Vaginal wall, NOS - FIGO Stage IIIA + Bladder wall + Bladder, NOS excluding mucosa + Bullous edema of bladder mucosa + Lower third of vagina + Rectal wall + Rectum, NOS excluding mucosa + Ureter, intra- and extramural + Vagina, lower third (not extending to pelvic wall) + Vulva - FIGO Stage IIIB + Described clinically as frozen pelvis + Hydronephrosis or nonfunctioning kidney + Pelvic wall(s) - FIGO Stage III [NOS] + Fallopian tube(s) + Ovary(ies) + Urethra |
| 3 | Regional lymph node(s) involved only - Aortic + Lateral aortic + Para-aortic + Periaortic - Iliac, NOS + Common + External + Internal (hypogastric) (obturator), NOS - Paracervical - Parametrial - Pelvic, NOS - Sacral, NOS + Lateral (laterosacral) + Middle (promontorial) (Gerota’s node) + Presacral + Uterosacral - Regional lymph node(s), NOS + Lymph node(s), NOS |
| 4 | Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3) |
| 7 | Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Bladder mucosa + Rectal mucosa + Sigmoid colon + Small intestine + FIGO Stage IVA, IVB, IV [NOS] - Distant lymph node(s), NOS + Inguinal + Mediastinal + Scalene + Supraclavicular - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 9 | Unknown if extension or metastasis |